ScienceDex / Researcher record
Harding, Christian
- Vaxnewmo, LLC (no department on record)
From the FY2022 NIH awards this investigator leads as contact PI. The department is the award's.
- Early Career
- Diverse Portfolio
NIH Funding · FY2022
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
View yearly values
| Fiscal year | Linked awards | Records | Rank |
|---|---|---|---|
| 2020 | $931,060 | 1 | #3,304 |
| 2021 | $992,959 | 1 | #9,379 |
| 2022 | $1,584,172 | 3 | #5,160 |
| 2023 | $1,591,366 | 3 | #5,311 |
Award activity
Awards through the years
NIH award records listing this researcher in each fiscal year.
- FY20201 record
- FY20211 record
- FY2022 · selected3 records
- FY20233 records
Each bar starts at zero. Annual records can include renewals of the same project; they are not a count of distinct career grants.
Publications
Loading publications…
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID unavailableSearch this ID in NIH RePORTER
- ORCID iD
- No ORCID iD on recordA researcher can add one by claiming this profile.
- ScienceDex PI coverage
- FY2020 through FY2023Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2026.
FY2022 award records by amount
NIH award records listing Harding, Christian as a PI. Multi-PI records show the full award amount for context.
- 5R44AI131742-04R44Contact PITowards a New Generation of Glycoengineered Pneumococcal Bioconjugate Vaccines$984.9Kaward amount
- 1R41AI167078-01R41Contact PIA capsule-based bioconjugate vaccine to prevent Klebsiella pneumoniae infections$300Kaward amount
- 1R42AI165116-01A1R42Contact PIA multivalent O-antigen bioconjugate vaccine for the prevention of Klebsiella pneumoniae infections$299.2Kaward amount
Award organization
Organizations that administered FY2022 awards listing Harding, Christian as a PI.
FY2022 award administered by Vaxnewmo, LLC (MO).
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2020First NIH AwardVaxnewmo, LLC
- 2020$500K Cumulative Funding
- 2020Entered Top 50% NationallyRanked #3304
- 2020Entered Top 25% NationallyRanked #3304
- 2021$1M Cumulative Funding
- 2022$2M Cumulative Funding
- 2023$5M Cumulative Funding